EP4408503A1 — Feedback mechanism for a medicament delivery device
Assigned to SHL Medical AG · Expires 2024-08-07 · 2y expired
What this patent protects
A feedback mechanism (15) for a medicament delivery device (1), comprising: a rotator (25), and a ring member (23) arranged coaxially with the rotator, wherein the rotator (25) and the ring member (23) are configured to be rotatable relative to each other, wherein one of the rota…
USPTO Abstract
A feedback mechanism (15) for a medicament delivery device (1), comprising: a rotator (25), and a ring member (23) arranged coaxially with the rotator, wherein the rotator (25) and the ring member (23) are configured to be rotatable relative to each other, wherein one of the rotator (25) and the ring member (23) has a radially resilient feedback structure (23a) and the other one of the rotator (25) and the ring member (23) has a first counter feedback structure (25b) configured to interact with the feedback structure (23a) when one of the rotator (25) and the ring member (23) is rotated relative to the other one of the rotator (25) and the ring member (23), wherein when the feedback structure (23a) interacts with the first counter feedback structure (25b) the feedback structure (23a) is configured to relax and hit the first 15counter feedback structure (23a) to thereby provide a first feedback sound.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.